CIBUS INC (CBUS) Fundamental Analysis & Valuation
NASDAQ:CBUS • US17166A1016
Current stock price
1.831 USD
-0.05 (-2.61%)
Last:
This CBUS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CBUS Profitability Analysis
1.1 Basic Checks
- CBUS had negative earnings in the past year.
- CBUS had a negative operating cash flow in the past year.
- CBUS had negative earnings in each of the past 5 years.
- CBUS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of CBUS (-41.66%) is comparable to the rest of the industry.
- With a Return On Equity value of -582.18%, CBUS is not doing good in the industry: 76.98% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.66% | ||
| ROE | -582.18% | ||
| ROIC | N/A |
ROA(3y)-54.21%
ROA(5y)-63.31%
ROE(3y)-315.39%
ROE(5y)-277.57%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for CBUS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. CBUS Health Analysis
2.1 Basic Checks
- CBUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
- CBUS has more shares outstanding than it did 1 year ago.
- CBUS has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, CBUS has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -4.41, we must say that CBUS is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of CBUS (-4.41) is comparable to the rest of the industry.
- CBUS has a Debt/Equity ratio of 10.77. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 10.77, CBUS is not doing good in the industry: 82.20% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -4.41 |
ROIC/WACCN/A
WACC5.94%
2.3 Liquidity
- A Current Ratio of 0.72 indicates that CBUS may have some problems paying its short term obligations.
- Looking at the Current ratio, with a value of 0.72, CBUS is doing worse than 88.39% of the companies in the same industry.
- A Quick Ratio of 0.72 indicates that CBUS may have some problems paying its short term obligations.
- CBUS has a worse Quick ratio (0.72) than 88.20% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.72 |
3. CBUS Growth Analysis
3.1 Past
- CBUS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.48%, which is quite impressive.
- The Revenue for CBUS has decreased by -14.62% in the past year. This is quite bad
- CBUS shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -31.34% yearly.
EPS 1Y (TTM)22.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.18%
Revenue 1Y (TTM)-14.62%
Revenue growth 3Y183.33%
Revenue growth 5Y-31.34%
Sales Q2Q%-12.79%
3.2 Future
- Based on estimates for the next years, CBUS will show a very strong growth in Earnings Per Share. The EPS will grow by 28.28% on average per year.
- CBUS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 150.09% yearly.
EPS Next Y35.71%
EPS Next 2Y19.94%
EPS Next 3Y30%
EPS Next 5Y28.28%
Revenue Next Year99.13%
Revenue Next 2Y104.5%
Revenue Next 3Y162.46%
Revenue Next 5Y150.09%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. CBUS Valuation Analysis
4.1 Price/Earnings Ratio
- CBUS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CBUS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CBUS's earnings are expected to grow with 30.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.94%
EPS Next 3Y30%
5. CBUS Dividend Analysis
5.1 Amount
- No dividends for CBUS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
CBUS Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:CBUS (3/30/2026, 1:23:08 PM)
1.831
-0.05 (-2.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-17 2026-03-17/amc
Earnings (Next)05-06 2026-05-06
Inst Owners17.36%
Inst Owner Change4.24%
Ins Owners24.88%
Ins Owner Change5.92%
Market Cap124.32M
Revenue(TTM)3.64M
Net Income(TTM)-127.08M
Analysts80
Price Target14.59 (696.83%)
Short Float %4.13%
Short Ratio4.3
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.47%
Min EPS beat(2)-34.52%
Max EPS beat(2)17.57%
EPS beat(4)2
Avg EPS beat(4)-3.28%
Min EPS beat(4)-34.52%
Max EPS beat(4)17.57%
EPS beat(8)3
Avg EPS beat(8)4.22%
EPS beat(12)3
Avg EPS beat(12)-144.79%
EPS beat(16)7
Avg EPS beat(16)-100.12%
Revenue beat(2)0
Avg Revenue beat(2)-46.82%
Min Revenue beat(2)-56.66%
Max Revenue beat(2)-36.97%
Revenue beat(4)0
Avg Revenue beat(4)-31.23%
Min Revenue beat(4)-56.66%
Max Revenue beat(4)-11.09%
Revenue beat(8)4
Avg Revenue beat(8)21.21%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.69%
EPS NQ rev (1m)11.11%
EPS NQ rev (3m)8.57%
EPS NY rev (1m)-0.45%
EPS NY rev (3m)-25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 34.16 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 5.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-2.38
EYN/A
EPS(NY)-1.53
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS0.05
BVpS0.32
TBVpS-3.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.66% | ||
| ROE | -582.18% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-54.21%
ROA(5y)-63.31%
ROE(3y)-315.39%
ROE(5y)-277.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 10.77 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 9.76% | ||
| Cap/Sales | 15.88% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | -4.41 |
F-Score3
WACC5.94%
ROIC/WACCN/A
Cap/Depr(3y)37.87%
Cap/Depr(5y)46.87%
Cap/Sales(3y)90.88%
Cap/Sales(5y)244.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.48%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.18%
EPS Next Y35.71%
EPS Next 2Y19.94%
EPS Next 3Y30%
EPS Next 5Y28.28%
Revenue 1Y (TTM)-14.62%
Revenue growth 3Y183.33%
Revenue growth 5Y-31.34%
Sales Q2Q%-12.79%
Revenue Next Year99.13%
Revenue Next 2Y104.5%
Revenue Next 3Y162.46%
Revenue Next 5Y150.09%
EBIT growth 1Y11.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.04%
EBIT Next 3Y42.29%
EBIT Next 5Y43.4%
FCF growth 1Y13.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.84%
OCF growth 3YN/A
OCF growth 5YN/A
CIBUS INC / CBUS Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for CIBUS INC?
ChartMill assigns a fundamental rating of 1 / 10 to CBUS.
What is the valuation status of CIBUS INC (CBUS) stock?
ChartMill assigns a valuation rating of 1 / 10 to CIBUS INC (CBUS). This can be considered as Overvalued.
Can you provide the profitability details for CIBUS INC?
CIBUS INC (CBUS) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for CBUS stock?
The Earnings per Share (EPS) of CIBUS INC (CBUS) is expected to grow by 35.71% in the next year.